1 / 9

Biosynthetic Human Milk Oligosaccharides (HMO) Market Growth, and Demand

Biosynthetic Human Milk Oligosaccharides (HMOs) Market is an emerging sector within the food and nutrition industry. HMOs are complex carbohydrates that are naturally found in human breast milk and play a crucial role in promoting the health and development of infants.

Stringentdatalytics
Download Presentation

Biosynthetic Human Milk Oligosaccharides (HMO) Market Growth, and Demand

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth Trends Analysis and Dynamic Demand, Forecast 2017 to 2032 Biosynthetic Human Milk Oligosaccharides (HMOs) Market is an emerging sector within the food and nutrition industry. HMOs are complex carbohydrates that are naturally found in human breast milk and play a crucial role in promoting the health and development of infants. Traditionally, HMOs have been obtained from human milk, which limits their availability and scalability for commercial purposes. However, recent advancements in biotechnology and synthetic biology have enabled the production of HMOs through biosynthesis. This process involves the fermentation of specific sugars using genetically engineered microorganisms to mimic the structure and function of naturally occurring HMOs. The biosynthetic HMOs market is primarily driven by the increasing awareness of the benefits of HMOs in infant nutrition. These oligosaccharides have been shown to have various health benefits, including supporting the development of a healthy gut microbiota, enhancing the immune system, and reducing the risk of infections and allergies in infants. The market is also fueled by the growing demand for alternative sources of HMOs. Biosynthetic production offers a more sustainable and scalable solution compared to traditional methods that rely on human milk or animal sources. It allows for consistent and controlled production, ensuring a reliable supply of HMOs for infant formula manufacturers and other food and beverage companies. Furthermore, the biosynthetic HMOs market is driven by the increasing prevalence of lactose intolerance and milk allergies. HMOs provide a lactose- free alternative for infants who cannot consume traditional dairy-based products, making them an attractive option for formula feeding. Click Here, To Get Free Sample Report: https://stringentdatalytics.com/sample-request/biosynthetic-human-milk- oligosaccharides-(hmos)-market/6234/ sales@stringentdatalytics.com

  2. Market Segmentations: Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market: By Company • DSM (Glycom) • Dupont (Inbiose) • BASF (Glycosyn) • Chr. Hansen (Jennewein) • Abbott • FrieslandCampina Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market: By Type • 2′-FL & 3-FL • LNT & LNnT, etc. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market: By Application • Infant Formula • Other Applications Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market: Regional Analysis All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Biosynthetic Human Milk Oligosaccharides (HMOs) market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America. Table of Contents: sales@stringentdatalytics.com

  3. 1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate by Type: 2018 VS 2023 VS 2032 1.2.2 2'-FL & 3-FL 1.2.3 LNT & LNnT, etc. 1.3 Market by Application 1.3.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth by Application: 2018 VS 2023 VS 2032 1.3.2 Infant Formula 1.3.3 Other Applications 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Perspective (2017-2032) 2.2 Biosynthetic Human Milk Oligosaccharides (HMOs) Growth Trends by Region 2.2.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region: 2018 VS 2023 VS 2032 2.2.2 Biosynthetic Human Milk Oligosaccharides (HMOs) Historic Market Size by Region (2017-2023) 2.2.3 Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Region (2023-2032) 2.3 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Dynamics 2.3.1 Biosynthetic Human Milk Oligosaccharides (HMOs) Industry Trends 2.3.2 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Drivers 2.3.3 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Challenges 2.3.4 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Biosynthetic Human Milk Oligosaccharides (HMOs) Players by Revenue 3.1.1 Global Top Biosynthetic Human Milk Oligosaccharides (HMOs) Players by Revenue (2017-2023) sales@stringentdatalytics.com

  4. 3.1.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Players (2017-2023) 3.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue 3.4 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Concentration Ratio 3.4.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue in 2022 3.5 Biosynthetic Human Milk Oligosaccharides (HMOs) Key Players Head office and Area Served 3.6 Key Players Biosynthetic Human Milk Oligosaccharides (HMOs) Product Solution and Service 3.7 Date of Enter into Biosynthetic Human Milk Oligosaccharides (HMOs) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Biosynthetic Human Milk Oligosaccharides (HMOs) Breakdown Data by Type 4.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Historic Market Size by Type (2017-2023) 4.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Type (2023-2032) 5 Biosynthetic Human Milk Oligosaccharides (HMOs) Breakdown Data by Application 5.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Historic Market Size by Application (2017-2023) 5.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Application (2023-2032) 6 North America 6.1 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2017-2032) 6.2 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth Rate by Country: 2018 VS 2023 VS 2032 6.3 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market sales@stringentdatalytics.com

  5. Size by Country (2017-2023) 6.4 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2023-2032) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2017-2032) 7.2 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth Rate by Country: 2018 VS 2023 VS 2032 7.3 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2017-2023) 7.4 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2023-2032) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2017-2032) 8.2 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth Rate by Region: 2018 VS 2023 VS 2032 8.3 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (2017-2023) 8.4 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (2023-2032) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market sales@stringentdatalytics.com

  6. Size (2017-2032) 9.2 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth Rate by Country: 2018 VS 2023 VS 2032 9.3 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2017-2023) 9.4 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2023-2032) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2017-2032) 10.2 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth Rate by Country: 2018 VS 2023 VS 2032 10.3 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2017-2023) 10.4 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2023-2032) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 DSM (Glycom) 11.1.1 DSM (Glycom) Company Detail 11.1.2 DSM (Glycom) Business Overview 11.1.3 DSM (Glycom) Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction 11.1.4 DSM (Glycom) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2023) 11.1.5 DSM (Glycom) Recent Development 11.2 Dupont (Inbiose) 11.2.1 Dupont (Inbiose) Company Detail 11.2.2 Dupont (Inbiose) Business Overview 11.2.3 Dupont (Inbiose) Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction 11.2.4 Dupont (Inbiose) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2023) sales@stringentdatalytics.com

  7. 11.2.5 Dupont (Inbiose) Recent Development 11.3 BASF (Glycosyn) 11.3.1 BASF (Glycosyn) Company Detail 11.3.2 BASF (Glycosyn) Business Overview 11.3.3 BASF (Glycosyn) Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction 11.3.4 BASF (Glycosyn) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2023) 11.3.5 BASF (Glycosyn) Recent Development 11.4 Chr. Hansen (Jennewein) 11.4.1 Chr. Hansen (Jennewein) Company Detail 11.4.2 Chr. Hansen (Jennewein) Business Overview 11.4.3 Chr. Hansen (Jennewein) Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction 11.4.4 Chr. Hansen (Jennewein) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2023) 11.4.5 Chr. Hansen (Jennewein) Recent Development 11.5 Abbott 11.5.1 Abbott Company Detail 11.5.2 Abbott Business Overview 11.5.3 Abbott Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction 11.5.4 Abbott Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2023) 11.5.5 Abbott Recent Development 11.6 FrieslandCampina 11.6.1 FrieslandCampina Company Detail 11.6.2 FrieslandCampina Business Overview 11.6.3 FrieslandCampina Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction 11.6.4 FrieslandCampina Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2023) 11.6.5 FrieslandCampina Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach sales@stringentdatalytics.com

  8. 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details Visit Report Page for More Details: https://stringentdatalytics.com/reports/biosynthetic-human-milk- oligosaccharides-(hmos)-market/6234/ Objectives of Biosynthetic Human Milk Oligosaccharides (HMOs) Market Study: Market Size and Growth Analysis: Determine the current market size of biosynthetic HMOs and analyze the historical and projected growth rates. This objective helps understand the market’s potential and attractiveness for investors and industry players. Competitive Analysis: Evaluate the competitive landscape of the biosynthetic HMOs market by studying the key players, their market share, product offerings, and strategies. This objective helps identify the strengths and weaknesses of competitors and provides insights into market positioning and differentiation. Customer Analysis: Understand the preferences, needs, and behaviors of the target customers for biosynthetic HMOs. This objective involves analyzing customer demographics, purchasing patterns, and factors influencing their decision-making process. Such insights help in product development, marketing strategies, and effective targeting of potential customers. Market Trends and Opportunities: Identify the emerging trends, technological advancements, and regulatory factors impacting the biosynthetic HMOs market. This objective enables the identification of potential growth opportunities, areas for innovation, and risks that could affect market dynamics. Pricing Analysis: Evaluate the pricing strategies employed in the biosynthetic HMOs market and analyze their impact on demand and market positioning. This objective helps understand price elasticity, competitive pricing dynamics, and the potential for premium pricing based on product differentiation. Distribution Channel Analysis: Study the distribution channels utilized in the biosynthetic HMOs market and their effectiveness. This objective involves sales@stringentdatalytics.com

  9. understanding the role of wholesalers, retailers, e-commerce platforms, and direct sales channels in reaching the target market efficiently. Regulatory and Legal Landscape: Assess the regulatory environment governing the production, marketing, and use of biosynthetic HMOs. This objective helps identify compliance requirements, potential barriers to entry, and risks associated with changing regulations. About US: Stringent Datalytics offers both custom and syndicated market research reports. Custom market research reports are tailored to a specific client’s needs and requirements. These reports provide unique insights into a particular industry or market segment and can help businesses make informed decisions about their strategies and operations. Syndicated market research reports, on the other hand, are pre-existing reports that are available for purchase by multiple clients. These reports are often produced on a regular basis, such as annually or quarterly, and cover a broad range of industries and market segments. Syndicated reports provide clients with insights into industry trends, market sizes, and competitive landscapes. By offering both custom and syndicated reports, Stringent Datalytics can provide clients with a range of market research solutions that can be customized to their specific needs. Contact US: Stringent Datalytics Contact No - +1 346 666 6655 Email Id - sales@stringentdatalytics.com Web - https://stringentdatalytics.com/ Follow US: https://www.linkedin.com/company/stringent-datalytics/ https://twitter.com/StringentDataL https://www.facebook.com/stringentdatalytics/ sales@stringentdatalytics.com

More Related